Saturday, April 11, 2026

Chest Pain and Heaviness Prescription (Apr 2026)

See Other Medications For Pain Management <<< Previously Next >>>

Hospital / Header

Miracles Healthcare
Apollo Cradle & Children’s Hospital
Apollo Spectra Hospitals

OPD Prescription

Vitals

Pulse: 68 bpm
BP: 100/70 mmHg
SpO₂: 98%

Chief Complaints

c/o (complains of): chest heaviness / pain

Orders (Tests advised)

Electrocardiogram (ECG) → “Brady” (likely bradycardia suspected)
X-Ray Chest PA View

Doctor’s Notes (Handwritten – interpreted)

“Avoid heavy work / exertion” (approx interpretation)

Medications

Ecosprin-AV 75
- OD (once daily)
Nexpro-L / Nexpro-MR (unclear, likely acid reflux medicine)
- 1 tablet daily
K… (likely potassium or supplement)
- Once a day
- (10 days mentioned)

Further Advice / Tests

Physiotherapy
HRCT Chest (High-resolution CT scan)
Echo + TMT
- Echo = Echocardiography (heart ultrasound)
- TMT = Treadmill test (stress test)

Doctor

Dr. Saurabh Jindal
MBBS, DNB (Gen Medicine)
Visiting Consultant – Internal Medicine

🧠 Simple Explanation (What this means)

🩺 1. What’s going on?

The patient has chest heaviness/pain
Doctor wants to rule out:
- Heart issues
- Lung issues
- Muscle-related pain

❤️ 2. Why these tests?

ECG: checks heart rhythm
- “Brady” suggests slow heart rate (bradycardia) concern
X-ray chest: checks lungs, infection, or structural issues
Echo + TMT:
- Echo → heart structure & function
- TMT → how heart behaves under stress
HRCT chest:
- Detailed lung scan (more precise than X-ray)

💊 3. Medicines meaning

Ecosprin-AV 75
- Blood thinner (aspirin-based)
- Helps prevent clot-related heart issues
Nexpro (likely)
- Reduces acidity / GERD
- Chest pain can sometimes be from acid reflux
Potassium / supplement
- Likely to support electrolytes or general health

⚠️ 4. Important Observations

BP: 100/70 → slightly low but usually okay
Pulse: 68 → normal
SpO₂: 98% → excellent oxygen level

👉 So vitals are stable — this is good.

🧘 5. Lifestyle Advice

Avoid heavy physical exertion (important)
Follow up with tests to confirm diagnosis

⚡ Summary in one line

Doctor is being cautious about possible heart or chest-related issues, starting basic treatment + recommending tests to rule out serious causes.

Some corrections by 'Gemini 3.1 Thinking'

THIS IS MORE ACCURATE.

Prescribed Medications

The doctor has prescribed three primary medications in the "Adv." (Advice) box:

Esobils-DSR (or similar brand of Esomeprazole + Domperidone)
- Dosage: 1 capsule daily on an empty stomach.
- Duration: 10 days (indicated by the circled "10").
- Common Use: For acidity, heartburn, or GERD.
Nucoxia-MR (Etoricoxib + Thiocolchicoside)
- Dosage: 1 tablet once daily.
- Duration: 5 days.
- Common Use: A combination of a painkiller and a muscle relaxant, often used for musculoskeletal pain.
Kenberry K (Cranberry extract + Potassium Citrate)
- Dosage: 1 tablet once daily.
- Duration: 10 days.
- Common Use: Generally used to maintain urinary tract health or manage urine acidity.

Further Investigations & Tests

The doctor has requested the following additional diagnostic tests to further evaluate the chest pain:

HRCT Chest: A high-resolution CT scan of the lungs.
Echo + TMT: An Echocardiogram (heart ultrasound) and a Treadmill Test (stress test).
Physiotherapy: Suggested as part of the treatment plan.

Other Clinical Notes

Vitals: BP is 100/70 mmHg, and Pulse is 68 bpm.
ECG Note: The doctor wrote "Brady," which likely refers to Bradycardia (a slower than normal heart rate).
X-Ray Note: The doctor noted "↑ BVM," which usually stands for Increased Bronchovascular Markings in the lungs.
Activity Advice: The prescription explicitly notes to "Avoid weight bearing" (avoid lifting heavy weights).

Thursday, April 9, 2026

Honoring My Friends

My Meditations <<< Previously Next >>>

This is a debatable post – reason being: I am not in touch with any of the people about whom this post is.

People very often have asked me “who my friends are?”
And I have fallen short of an answer for most of the recent years – my list would be like one or two people long.
For my years (2018-2022) in Chandigarh at Infosys, it was Anil Dahiya. He was like my friend, mentor, emotional support, my go-to person for most things but then he moved to the US from the Ford project and I moved to Delhi. I think I last met / hung out with him in 2021.

Well, I am happy as I am writing about Anil, otherwise I didn’t have him in mind when I was thinking of this post: I was thinking about Rohit Sud, Vikas Jain and Yajuvendra Gupta instead.
And so now I will make this post about four people instead of three.

Anil is like an idol to me, my role model.
I admire him most for his strength to face the painful, life-altering disease of Ankylosing Spondylitis. And I regret writing this because he had told me last time (in 2021-2022ish) that he doesn’t want the world (friends, family or at work place) to know that he has this illness because Anil doesn’t want their pity, he wants their respect.

In my hindsight from my time in Chandigarh, I only remember being friends with two people: Anil Dahiya and Rohit Sud (though Rohit had quit Infosys in Nov 2019 in about 1 year and 8 months to move back to Delhi – but I was in touch with him on calls – The only person I used to call).

The thing about Anil and Rohit is this: They both teach you the philosophy of YOLO (You Only Live Once) – though neither of them have done anything for their own guilty pleasures / mischievous things that I am aware of. They both maintained a very clear, clean and disciplined image in my eyes – partly the reason why I adore them so much.

They didn’t share their difficulties with me and in contrast, they guided me through my tough times.

~~~

I came to know Vikas and Yajuvendra from my past workplaces. Vikas from Webplant and Yajuvendra from Mobileum. So they are both known to me for over 10+ years.

What Vikas and Yajuvendra teach me isn’t YOLO precisely but both of their lives do teach things on similar lines.
Vikas and Yajuvendra believed in enjoying what they did – otherwise (with a very high chance) they would stop doing it (eventually if not immediately).

One of their qualities that has definitely rubbed on me is: straightforwardedness (which I realized lately is also a Jain tenet practiced in Daslakshan days).
They express themselves so clearly, in such simple words that it would be understandable even to a five year old.

They are both hard working and look after their families (wife and children – Yaju has two (now) grown-up boys and Vikas has a daughter, Shivanshi who might have entered school) as responsible people.

One very contrasting thing about Vikas and Yajuvendra is how they see money: Vikas is definitely money-hungry, while Yaju practices contentment. And this reflects very clearly in their interactions with others.

Religiously and community-wise also I am able to connect with them: Vikas is Digambar Jain, and Yaju (though not Jain) is a Baniya (same as Jains 😀)

~~~

PS:
All four are senior to me years, age and experience wise.
All four are married.
Three also have got kids – Rohit is yet to get there.
And I am a 34 years old bachelor.

Dated: 2026 Apr 10, 7.30 AM

Tuesday, April 7, 2026

Nifty50’s 4-month decline is rare -- Does history signal a rebound for the Indian stock market?

Lessons in Investing Other Articles on Nifty50 <<< Previously

For Nifty episodes involving 4 or more consecutive negative months and measuring returns from the end of the full streak, the subsequent outcomes have historically been strong.

A rare occurrence for the benchmark Nifty 50 index—four consecutive months of decline—has dampened investor sentiment. However, historical trends suggest such phases have often improved the odds of stronger future returns.

Markets rarely move in a straight line, and periods of sustained decline have typically been followed by recovery, according to DSP Mutual Fund’s April edition of its Netra report.

Data shows that four straight monthly declines in the Nifty 50 are uncommon. In March, the index recorded a 11.3% loss—its worst monthly fall in six years—marking the fourth consecutive monthly drop during which it lost 15%. Such a streak of four or more months of losses has occurred only seven times historically, the fund house noted.

For Nifty episodes involving 4 or more consecutive negative months and measuring returns from the end of the full streak, the subsequent outcomes have historically been strong, the fund house said. According to its analysis, across the seven completed cases, the average return was 12.2% over three months, 22.4% over six months and 40.7% over a year; the median return was 13.9%, 17.0%, and 20.8%, respectively.

Negative streak length (Months)	Episodes	Share of all streaks	Avg full decline	Avg 3M return	Avg 6M return	Avg 1Y return
1 month	57	54.2%	-4.2%	10.4%	13.2%	22.4%
2 months	28	26.7%	-10.8%	9.6%	10.0%	21.0%
3 months	13	12.4%	-13.2%	3.7%	10.9%	21.9%
4+ months	7	6.7%	-23.3%	12.2%	22.4%	40.7%

But a historical trend cannot be the only factor behind the rebound.

Stock market outlook

These four months of pessimism, especially seen in March due to the US-Iran war, have made Nifty 50's valuations more palatable.

Nifty is trading below its long-period average multiples of 18.9x; while it is not cheap, it has certainly fallen between its fair and average valuations, making it a prudent time to start raising weightage in equities, opined DSP MF. The fund house also dropped its conservative stance on equities.

Echoing a similar positive view on stocks, Sunny Agrawal, Head of Fundamental Research at SBI Securities, said that the recent sell-off is largely driven by liquidity concerns and global uncertainty due to ongoing geopolitical tensions. "Valuations have already become attractive, and the earnings outlook remains strong for FY27 and FY28, particularly in the mid- and small-cap space. From a valuation perspective, conditions are now favourable."

He believes the time is right to accumulate quality businesses in your portfolio. He added that once the conflict is resolved in the coming weeks and once stability returns, there could be a solid runway for a stock market rally over the next two to three years.

The US-Israeli conflict with Iran has hammered domestic equities, as the crude oil spike amid supply disruptions has resulted in mass FPI exodus, rupee weakness and uncertainty regarding earnings growth.

Commenting on the market outlook, Dr VK Vijayakumar, Chief Investment Strategist at Geojit Financial Services, said that the market has largely discounted the known bad news. If the war escalates and Brent crude remains above $110 for long, India’s growth and corporate earnings will be hit, and the market will discount that with another round of correction, he noted.

Ref

Monday, April 6, 2026

Update on Llama Family of AI Models From Meta (Apr 2026)

See All on AI Model Releases
<<< Previously

What happened to the llama family of AI models?

The

Llama (Large Language Model Meta AI) family has evolved from a leaked research project into the industry standard for "open-weights" AI. Developed by Meta, these models are free for most users and can be run locally on personal hardware.

Current Status: Llama 4

As of April 2025, Meta has transitioned to the Llama 4 generation, which features "natively multimodal" capabilities—meaning it can understand text, images, audio, and video simultaneously.

Key models in the current lineup include:

Llama 4 Scout: A highly efficient multimodal model supporting a massive 10 million token context window, allowing it to process entire libraries of information at once.
Llama 4 Maverick: A 400-billion parameter model (with 17 billion active parameters via Mixture-of-Experts) designed for high-performance text and image understanding.
Llama 4 Behemoth: A massive "teacher" model with 288 billion active parameters, setting new benchmarks for non-reasoning tasks like math and multilinguality.

Evolution of the Family

Llama 1 (Feb 2023): Originally intended for researchers, it was famously leaked online shortly after release.
Llama 2 (July 2023): Explicitly released for commercial use, sparking the "local LLM" movement.
Llama 3 & 3.1 (April–July 2024): Introduced much larger parameter counts (up to 405B) and significantly improved multilingual support.
Llama 4 (April 2025): Shifted the focus to native multimodality and extreme context windows.

Impact and Availability

The Llama family is considered a successful "open" model, with over one billion downloads as of 2025. Developers can download and run these models without a subscription, unlike some competitors. The models are available through platforms like Hugging Face or Meta's official Llama site.

Creating a public link…

A copy of this chat will be included with your feedback

Has Meta stopped opensourcing it's LLMs?

Meta has

not fully stopped releasing "open-weights" models, but as of April 2026, the company has significantly shifted its strategy away from the "open-source everything" philosophy it championed in 2024.

While recent models like
Llama 4 Scout

and
Maverick

remain available for download and local use, Meta is increasingly moving toward a "closed" or proprietary model for its most powerful upcoming technology.

The Current Strategy Shift

The "Avocado" Model: Reports indicate that Meta's next frontier model, codenamed Avocado (expected in Q2 2026), will likely be closed-source. This would be Meta's first major departure from the Llama open-weight tradition, designed as a proprietary, "money-making" competitor to OpenAI and Google.
Safety & Superintelligence: Mark Zuckerberg has clarified that while Meta wants to lead in open source, it will no longer open-source "everything". Specifically, as models approach "superintelligence" levels, Meta cites safety concerns and the risk of adversarial use by state-level actors as reasons to keep certain weights private.
Commercial Pressures: After investing over $600 billion in AI infrastructure, Meta is under pressure to monetize its AI research directly through APIs and enterprise services rather than just giving the technology away for free.

What is Still "Open"?

Llama 4 Series: The "Scout" and "Maverick" versions released in 2025 are still available as open-weights models.
Community Ecosystem: Meta continues to support platforms like Hugging Face and partners like Nvidia and Databricks for hosting and fine-tuning existing Llama models.
Licensing Realities: It is important to note that the Open Source Initiative (OSI) and other purists have long argued Llama was never truly open source because Meta withheld training data and imposed usage restrictions on large companies.

Would you like to know more about the capabilities of Llama 4 or the specific licensing restrictions for large-scale commercial use?